Submission of Audited Financial Results for the quarter and year ended March 31, 2025
ENTERO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 7.5 pts less than Nifty Microcap 250 and 7.2 pts less than its Retailing peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Entero Healthcare Solutions Limited has submitted its audited financial results for the quarter and full year ended March 31, 2025, to the stock exchanges as required under listing regulations. The full text of the results, including income statement, balance sheet, cash flow statement, and auditor's report, was not provided in the input. Specific revenue, profit, margin, and balance sheet figures cannot be quoted as the detailed financial tables were not shared. Investors should refer to the complete filing on the NSE/BSE website for line-by-line numbers, segment performance, and the auditor's observations.
Audited annual results are a routine regulatory filing and on their own are not a catalyst for sharp stock moves. The actual reaction, if any, will depend on whether reported revenue, profit, and margins beat or miss market expectations, which cannot be determined from the headline alone.